BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Ovarian cancer AND STK11, LKB1, 6794, ENSG00000118046, Q15831, PJS AND Treatment
28 results:

  • 1. DIRAS3 induces autophagy and enhances sensitivity to anti-autophagic therapy in KRAS-driven pancreatic and ovarian carcinomas.
    Bildik G; Gray JP; Mao W; Yang H; Ozyurt R; Orellana VR; De Wever O; Carey MS; Bast RC; Lu Z
    Autophagy; 2024 Mar; 20(3):675-691. PubMed ID: 38169324
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Phase I Study of mTORC1/2 Inhibitor Sapanisertib (CB-228/TAK-228) in Combination with Metformin in Patients with mTOR/AKT/PI3K Pathway Alterations and Advanced Solid Malignancies.
    Subbiah V; Coleman N; Piha-Paul SA; Tsimberidou AM; Janku F; Rodon J; Pant S; Dumbrava EEI; Fu S; Hong DS; Zhang S; Sun M; Jiang Y; Roszik J; Song J; Yuan Y; Meric-Bernstam F; Naing A
    Cancer Res Commun; 2024 Feb; 4(2):378-387. PubMed ID: 38126764
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Extended genetic analysis and tumor characteristics in over 4600 women with suspected hereditary breast and ovarian cancer.
    Öfverholm A; Törngren T; Rosén A; Arver B; Einbeigi Z; Haraldsson K; Ståhlbom AK; Kuchinskaya E; Lindblom A; Melin B; Paulsson-Karlsson Y; Stenmark-Askmalm M; Tham E; von Wachenfeldt A; Kvist A; Borg Å; Ehrencrona H
    BMC Cancer; 2023 Aug; 23(1):738. PubMed ID: 37563628
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. The effect of inhibition of receptor tyrosine kinase AXL on DNA damage response in ovarian cancer.
    Yeo XH; Sundararajan V; Wu Z; Phua ZJC; Ho YY; Peh KLE; Chiu YC; Tan TZ; Kappei D; Ho YS; Tan DSP; Tam WL; Huang RY
    Commun Biol; 2023 Jun; 6(1):660. PubMed ID: 37349576
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Celastrol as an emerging anticancer agent: Current status, challenges and therapeutic strategies.
    Wang C; Dai S; Zhao X; Zhang Y; Gong L; Fu K; Ma C; Peng C; Li Y
    Biomed Pharmacother; 2023 Jul; 163():114882. PubMed ID: 37196541
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Prevalence of Pathogenic Germline Mutations in 13 Hereditary cancer-Related Genes in Breast cancer Patients in Narathiwat Province, Thailand.
    Sukpan P; Kanokwiroon K; Sriplung H; Laochareonsuk W; Choochuen P; Auseng N; Wanawanakorn K; Sangkhathat S
    Asian Pac J Cancer Prev; 2023 Feb; 24(2):525-530. PubMed ID: 36853301
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Pancreatic cancer with Mutation in BRCA1/2, MLH1, and APC Genes: Phenotype Correlation and Detection of a Novel Germline BRCA2 Mutation.
    Vietri MT; D'Elia G; Caliendo G; Albanese L; Signoriello G; Napoli C; Molinari AM
    Genes (Basel); 2022 Feb; 13(2):. PubMed ID: 35205366
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Modeling High-Grade Serous ovarian Carcinoma Using a Combination of
    Teng K; Ford MJ; Harwalkar K; Li Y; Pacis AS; Farnell D; Yamanaka N; Wang YC; Badescu D; Ton Nu TN; Ragoussis J; Huntsman DG; Arseneau J; Yamanaka Y
    Cancer Res; 2021 Oct; 81(20):5147-5160. PubMed ID: 34301761
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Non-Peutz-Jeghers syndrome-associated ovarian sex cord tumor with annular tubules treated by radiotherapy: a case report and literature review.
    Li C; Aishajiang R; Teng Y; Xu T; Ding L; Dong L
    J Int Med Res; 2021 Mar; 49(3):300060521996563. PubMed ID: 33715493
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Time Trends in Receipt of Germline Genetic Testing and Results for Women Diagnosed With Breast cancer or ovarian cancer, 2012-2019.
    Kurian AW; Ward KC; Abrahamse P; Bondarenko I; Hamilton AS; Deapen D; Morrow M; Berek JS; Hofer TP; Katz SJ
    J Clin Oncol; 2021 May; 39(15):1631-1640. PubMed ID: 33560870
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Precision medicine phase II study evaluating the efficacy of a double immunotherapy by durvalumab and tremelimumab combined with olaparib in patients with solid cancers and carriers of homologous recombination repair genes mutation in response or stable after olaparib treatment.
    Fumet JD; Limagne E; Thibaudin M; Truntzer C; Bertaut A; Rederstorff E; Ghiringhelli F
    BMC Cancer; 2020 Aug; 20(1):748. PubMed ID: 32778095
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Genetic Testing and Screening Recommendations for Patients with Hereditary Breast cancer.
    Bharucha PP; Chiu KE; François FM; Scott JL; Khorjekar GR; Tirada NP
    Radiographics; 2020; 40(4):913-936. PubMed ID: 32469631
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. ovarian Sertoli cell tumours: practical points.
    Gheorghisan-Galateanu AA; Carsote M; Terzea D; Valea A; Ghemigian A
    J Pak Med Assoc; 2020 Jan; 70(1):129-133. PubMed ID: 31954037
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Androgen-Secreting ovarian Tumors.
    Macut D; Ilić D; Mitrović Jovanović A; Bjekić-Macut J
    Front Horm Res; 2019; 53():100-107. PubMed ID: 31499493
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Time to incorporate germline multigene panel testing into breast and ovarian cancer patient care.
    Graffeo R; Livraghi L; Pagani O; Goldhirsch A; Partridge AH; Garber JE
    Breast Cancer Res Treat; 2016 Dec; 160(3):393-410. PubMed ID: 27734215
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Metformin use and gynecological cancers: A novel treatment option emerging from drug repositioning.
    Gadducci A; Biglia N; Tana R; Cosio S; Gallo M
    Crit Rev Oncol Hematol; 2016 Sep; 105():73-83. PubMed ID: 27378194
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Intact lkb1 activity is required for survival of dormant ovarian cancer spheroids.
    Peart T; Ramos Valdes Y; Correa RJ; Fazio E; Bertrand M; McGee J; Préfontaine M; Sugimoto A; DiMattia GE; Shepherd TG
    Oncotarget; 2015 Sep; 6(26):22424-38. PubMed ID: 26068970
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Management and prognosis of patients with ovarian sex cord tumor with annular tubules: a retrospective study.
    Qian Q; You Y; Yang J; Cao D; Zhu Z; Wu M; Chen J; Lang J; Shen K
    BMC Cancer; 2015 Apr; 15():270. PubMed ID: 25886261
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Synergistic effects of eukaryotic co-expression plasmid-based STAT3-specific siRNA and lkb1 on ovarian cancer in vitro and in vivo.
    Pan Y; Zhang L; Zhang X; Liu R
    Oncol Rep; 2015 Feb; 33(2):774-82. PubMed ID: 25420630
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Metastatic ovarian sex-cord stromal tumor with annular tubules in a patient without Peutz-Jeghers syndrome.
    Dart K; Schwartzenfeld T; Brandes W; D'Errico A; Stender M
    Ear Nose Throat J; 2014 Jun; 93(6):E9-E13. PubMed ID: 24932834
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 2.